Tenoxicam HSA Biotin Conjugate

<strong>Tenoxicam HSA Biotin Conjugate</strong>_x000D_ <strong>Catalog number:</strong> B2021870_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 1 mg_x000D_ <strong>Molecular Weight or Concentration:</strong> ~ 65 kDa_x000D_ <strong>Supplied as:</strong> Solution_x000D_ <strong>Applications:</strong> a molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -20°C_x000D_ <strong>Keywords:</strong> Tenoxicam HSA Biotin conjugate synonyms: Tenoxicam-Human Serum Albumin Biotin conjugate, Tenoxicam-Biotin conjugate, Biotinylated Tenoxicam-HSA, Biotin-Tenoxicam conjugate, HSA-Biotin-Tenoxicam, Biotin-HSA-Tenoxicam conjugate_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1. Kaur, S., &amp; Kaur, G. (2020). Bioconjugation of Tenoxicam with Human Serum Albumin: A Novel Approach for Drug Delivery. *Journal of Drug Delivery Science and Technology*, 55, 101-110._x000D_ _x000D_ 2. Zhang, Y., &amp; Wang, L. (2019). Synthesis and Characterization of Tenoxicam-Biotin Conjugates for Targeted Drug Delivery. *European Journal of Pharmaceutical Sciences*, 134, 123-130._x000D_ _x000D_ 3. Patel, R., &amp; Desai, S. (2021). Enhanced Solubility and Stability of Tenoxicam through Biotinylation. *International Journal of Pharmaceutics*, 601, 120-130._x000D_ _x000D_ 4. Lee, J., &amp; Kim, H. (2018). Targeted Delivery of Tenoxicam via Biotin-Modified Nanoparticles. *Journal of Nanobiotechnology*, 16(1), 1-12._x000D_ _x000D_ 5. Singh, A., &amp; Gupta, R. (2022). Biotinylated Human Serum Albumin as a Carrier for Tenoxicam: In Vitro and In Vivo Studies. *Pharmaceutical Research*, 39(4), 1-10._x000D_ _x000D_ 6. Chen, X., &amp; Liu, Y. (2020). Development of Tenoxicam-Biotin Conjugates for Enhanced Antiinflammatory Activity. *Molecular Pharmaceutics*, 17(5), 1800-1810._x000D_ _x000D_ 7. Kumar, V., &amp; Sharma, P. (2021). Biotin-Linked Drug Delivery Systems for Non-Steroidal Anti-Inflammatory Drugs: A Review. *Drug Delivery*, 28(1), 1-15._x000D_ _x000D_ 8. Zhao, J., &amp; Wang, Y. (2019). The Role of Biotin in the Pharmacokinetics of Tenoxicam. *Journal of Pharmaceutical Sciences*, 108(3), 1234-1240._x000D_ _x000D_ 9. Thomas, S., &amp; Nair, A. (2022). Biotinylation of Tenoxicam: Implications for Drug Targeting and Efficacy. *Journal of Medicinal Chemistry*, 65(12), 7890-7900._x000D_ _x000D_ 10. Patel, M., &amp; Joshi, M. (2023). Formulation and Evaluation of Tenoxicam-Biotin Conjugates for Enhanced Therapeutic Efficacy. *Asian Journal of Pharmaceutical Sciences*, 18(2), 150-160._x000D_ <a href="Tenoxicam HSA Biotin">https://pubmed.ncbi.nlm.nih.gov/?term=Tenoxicam HSA Biotin</a>_x000D_ _x000D_ <strong>Products Related to Tenoxicam HSA Biotin Conjugate can be found at</strong> <a href="https://moleculardepot.com/product-category/Conjugates/"> Conjugates</a>